Samrat Pharmachem Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	71.12	21.63	166.31	171.85	53.33
Depreciation & Amortization	6.53	6.46	6.42	5.94	4.93
Other Amortization	0.02	0.01	0.01	0.01	0
Loss (Gain) From Sale of Assets	0.95	-0.18	-	0.23	0.18
Loss (Gain) From Sale of Investments	-4.05	-9.87	-0.23	-0.08	-
Provision & Write-off of Bad Debts	-	-	-	0.23	-0.01
Other Operating Activities	16.24	-22.23	-25.7	54.35	9.48
Change in Accounts Receivable	127.45	-176.06	-80.99	-106.09	-51.93
Change in Inventory	-173.28	118.51	-201.12	-10.16	73.68
Change in Accounts Payable	-91.07	157.88	84.89	57.33	-54.29
Change in Other Net Operating Assets	-54.81	-2.03	-43.96	1.13	12.61
Operating Cash Flow	-100.91	94.12	-94.37	174.74	47.98
Operating Cash Flow Growth	-	-	-	264.22%	-
Capital Expenditures	-5.07	-6.67	-14.59	-12.76	-27.29
Sale of Property, Plant & Equipment	-	0.18	0.99	0.76	-
Investment in Securities	1.33	-0.62	-18.45	-0.02	-13.5
Other Investing Activities	3.69	3.05	2	1.38	11.55
Investing Cash Flow	-0.05	-4.06	-30.05	-10.64	-29.23
Short-Term Debt Issued	14.6	-	111.4	-	-
Total Debt Issued	14.6	-	111.4	-	-
Short-Term Debt Repaid	-	-102.05	-	-12.74	-3.03
Long-Term Debt Repaid	-	-	-	-	-3.12
Total Debt Repaid	-	-102.05	-	-12.74	-6.15
Net Debt Issued (Repaid)	14.6	-102.05	111.4	-12.74	-6.15
Common Dividends Paid	-3.09	-3.09	-3.09	-	-
Other Financing Activities	-6.74	-6.87	-12.32	-6.75	-12.75
Financing Cash Flow	4.77	-112.01	95.99	-19.49	-18.9
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0
Net Cash Flow	-96.19	-21.95	-28.43	144.62	-0.16
Free Cash Flow	-105.99	87.45	-108.96	161.98	20.69
Free Cash Flow Growth	-	-	-	682.87%	-
Free Cash Flow Margin	-3.71%	3.10%	-3.51%	7.30%	1.16%
Free Cash Flow Per Share	-34.30	28.30	-35.27	52.42	6.70
Cash Interest Paid	6.74	6.87	12.32	6.75	12.75
Cash Income Tax Paid	14.52	29.66	95	15.34	22.54
Levered Free Cash Flow	-124.04	85.05	-126.9	134.99	2.56
Unlevered Free Cash Flow	-121	88.51	-121.09	137.27	8.42
Change in Working Capital	-191.72	98.31	-241.18	-57.79	-19.92

Source: S&P Global Market Intelligence. Standard template. Financial Sources.